Acumen Pharmaceuticals (ABOS) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
ABOS is expected to report earnings to fall 8.42% to -45 cents per share on March 31
Q4'24
Est.
$-0.46
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.11
The last earnings report on November 12 showed earnings per share of -50 cents, missing the estimate of -36 cents. With 64.98K shares outstanding, the current market capitalization sits at 142.39M.